2Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idopathic dilated cardiomyopathy[J]. Am J Cardiol, 1999, 83:376-382.
3Yamaoka M, Yamaguchi S, Okuyama M, et al. Anti - inflammatory cytokine profile in human heart failure: behavior of interleukin- 10 in association with tumor necrosis factor- alpha[J]. Jpn Circ J, 1999, 63(12) :951-956.
4Bolger AP, Sharma R, Haehling S, et al. Effect of interleukin - 10 on the production of tumor necrosis factor- alpha by peripheral blood mononuclear cells from patients with chronic heart failure[J]. Am J Cardiol, 2002, 90(40) :384-389.
5Tousoulis D, Homaei H, Abmed N, et al. Increased plasma adhesion molecule levels in patients with heart failure who have ischemic heart disease and dilated cardiomyopathy[J]. Am Heart J,2001, 141(2) :277-280.
6Yang Z, Zingarelli B, Szabo C. Crucial role of endogenous interleukin 10 production in myocardial ischaemia reperfusion injury[J]. Circulation, 2000, 101(9) :1019-1026.
7Frangogiannis NG, Smith CW, Entman ML, et al. The inflammatory response in myocardial infarction[J]. Cardiovasc Res, 2002,53(1) :31-47.
8Mostafa Mtairag E, Chollet - Martin S, Oudghiri M, et al. Effects of interleukin - 10 on monocyte/endothelial cell adhesion and MMP - 9/TIMP- 1 secretion[J]. Cardiovasc Res, 9.001, 49(4) :889.-890.
9De Lorenzo F, Saba N, Kakkar VV. Blood coagulation in patients with chronic heart failure: evidence for hypercoagtdable state and potential for pharmacological intervention [J ]. Drugs, 2003. 63(6):565-576.
10Lindmark E, Tenno T, Chen J, et al. IL 10 inhibits LPS induced human monocyte tissue factor expession in whole blood[J]. Br J Haematol, 1998, 109.(2) :597-604.